Document is current

Article History

Received: 7 March 2026

Accepted: 11 April 2026

First Online: 25 April 2026

Declarations

:

: Written informed consent for publication was obtained from the patient.

: TT received Honoraria from Sanofi, Takeda, AbbVie, Janssen, Bristol-Myers Squibb, Chugai, Fujimoto, Kyowa Kirin, Ono, Novartis, PharmaEssentia, Meiji Seika, Genmab, research funding from GlaxoSmithKline, AbbVie, Perseus Proteomics, Pfizer, Janssen, Bristol-Myers Squibb, and consulting fees from Janssen, GlaxoSmithKline, Sanofi.MH has received Honoraria from Asahi Kasei, Nippon Shinyaku, AbbVie, Nippon Kayaku, Alexion Pharma, Chugai, Daiichi Sankyo, AstraZeneca, Otsuka, Amgen, Janssen, Novartis, Gilead Sciences, Bristol-Myers Squibb, PharmaEssentia, MSD, Kyowa Kirin, Eisai, Genmab, Argenx, Pfizer, IVF Osaka Clinic, Meiji Seika, Mallinckrodt, Abbott, H.U. FRONTIER, Osaka Medical Association, Sanofi, Ono, Astellas, research funding from Nippon Shinyaku, Labcorp, Bristol-Myers Squibb, Sumitomo, consulting fees from Kyowa Kirin, Mochida, Ono, donation from Mochida, Asahi Kasei, Japan Blood Products Organization, Otsuka, TAIHO, Chugai, Kyowa Kirin, JCR PHARMACEUTICALS, Sumitomo, Nippon Kayaku, Sekisui Medical.